Abdel-Qadir et al. demonstrated that women on statins had a significantly lower risk of HF hospitalisation after receiving anthracycline-based chemotherapy for early breast cancer, and potentially lower risk in those receiving HER2 targeted therapy as well (152). The gene discussed is ERBB2; the disease is breast cancer.